ASMTL | Acetylserotonin O-methyltransferase-like | | | | | | Expressed in all |
AKAP17A | A kinase (PRKA) anchor protein 17A | | | | | | Expressed in all |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
MSL3 | Male-specific lethal 3 homolog (Drosophila) | Plasma proteins
| | | | | Expressed in all |
TCEANC | Transcription elongation factor A (SII) N-terminal and central domain containing | | | | | | Mixed |
OFD1 | Oral-facial-digital syndrome 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
GEMIN8 | Gem (nuclear organelle) associated protein 8 | | | | | | Expressed in all |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |
PIR | Pirin (iron-binding nuclear protein) | Enzymes Plasma proteins
| | | | | Expressed in all |
CA5B | Carbonic anhydrase VB, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
SYAP1 | Synapse associated protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
RBBP7 | Retinoblastoma binding protein 7 | | | | | | Expressed in all |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
SH3KBP1 | SH3-domain kinase binding protein 1 | Cytoskeleton related proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
SMS | Spermine synthase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
PRDX4 | Peroxiredoxin 4 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
POLA1 | Polymerase (DNA directed), alpha 1, catalytic subunit | Enzymes FDA approved drug targets
| | | | | Expressed in all |
TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | | | | | | Expressed in all |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
CXorf38 | Chromosome X open reading frame 38 | | | | | | Expressed in all |
USP9X | Ubiquitin specific peptidase 9, X-linked | Enzymes
| | | | | Expressed in all |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
NDUFB11 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
RBM10 | RNA binding motif protein 10 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
UBA1 | Ubiquitin-like modifier activating enzyme 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CDK16 | Cyclin-dependent kinase 16 | Enzymes
| | | | | Expressed in all |
USP11 | Ubiquitin specific peptidase 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
UXT | Ubiquitously-expressed, prefoldin-like chaperone | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
EBP | Emopamil binding protein (sterol isomerase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
WDR13 | WD repeat domain 13 | | | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes
| | | | | Mixed |
HDAC6 | Histone deacetylase 6 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
PQBP1 | Polyglutamine binding protein 1 | Disease related genes
| | | | | Expressed in all |
SLC35A2 | Solute carrier family 35 (UDP-galactose transporter), member A2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TFE3 | Transcription factor binding to IGHM enhancer 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
GPKOW | G patch domain and KOW motifs | | | | | | Expressed in all |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
GSPT2 | G1 to S phase transition 2 | | | | | | Expressed in all |
TSPYL2 | TSPY-like 2 | | | | | | Expressed in all |
SMC1A | Structural maintenance of chromosomes 1A | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PHF8 | PHD finger protein 8 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
GNL3L | Guanine nucleotide binding protein-like 3 (nucleolar)-like | | | | | | Expressed in all |
MAGED2 | Melanoma antigen family D, 2 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
APEX2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
RRAGB | Ras-related GTP binding B | | | | | | Expressed in all |